NDC 21922-002

NDC codes

FDA NDC Directory

Product NDC (as listed)21922-002Labeler and product segments. Claims need a package NDC.

Product NDC at billing width21922-0002Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
21922-002-01	21922000201	1 BOTTLE in 1 CARTON (21922-002-01) / 60 mL in 1 BOTTLEMarketed from Mar 4, 2019
21922-002-21	21922000221	1 BOTTLE in 1 CARTON (21922-002-21) / 30 mL in 1 BOTTLEMarketed from Jul 13, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phoaphate Topical Solution USP, 1%
Generic name (nonproprietary): clindamycin phosphate topical solution usp, 1%
Active ingredients: Clindamycin phosphate — 10 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Encube Ethicals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209914
Marketing start: Mar 4, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 21922-002_0babc3d6-8dfa-4034-8811-24af75b21048SPL ID 0babc3d6-8dfa-4034-8811-24af75b21048SPL set ID b2dfb76b-db09-43e7-8366-6791449a4918RxCUI 309333UNII EH6D7113I8UPC 0321922002218, 0321922002010
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N421922000201 followed by a unit qualifier and the quantity

Package 21922-0002-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 209914

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209914
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin Phoaphate Topical Solution USP, 1%clindamycin phosphate topical solution usp, 1%	Clindamycin phosphate 10 mg/mL	SolutionTopical	Northstar Rx LLC	72603-321
Clindamycin Phoaphate Topical USP, 1%clindamycin phosphate topical usp, 1%	Clindamycin phosphate 10 mg/mL	SolutionTopical	A-S Medication Solutions	50090-6592

Clindamycin Phoaphate Topical Solution USP, 1% NDC 21922-002